Health Care Archives - Page 407 of 478

1 minute read

This Stock Earns Price Bump, Bullish Pitch On Recent Positive Migraine Drug Data

September 21, 2:33 PM

Satsuma Pharmaceuticals Inc (NASDAQ:STSA) announced positive results from the ASCEND open-label, long-term safety trial for STS101 intranasal dry powder dihydroergotamine (DHE)…

STSA

1 minute read

With Upcoming Contentious Meeting, This Analyst Cuts Price Target On Spectrum Pharma

By Vandana Singh

September 21, 2:20 PM

On Tuesday, the FDA released briefing documents related to Spectrum Pharmaceutical Inc’s (NASDAQ:SPPI) application for poziotinib for treating patients with previously treated…

AZN

1 minute read

Peloton Stays Active With UnitedHealth – Renews & Expands Partnership

By Shivani Kumaresan

September 21, 2:15 PM

Peloton Interactive Inc (NASDAQ:PTON) and UnitedHealth Group (NYSE:UNH) have renewed and expanded their partnership. Under the newly expanded agreement, as many as…

PTON

1 minute read

After Two FDA Rejections, Fennec Pharma Lead Drug Scores US Approval For Chemo-Induced Hearing Loss

By Vandana Singh

September 21, 1:05 PM

The FDA approved Fennec Pharmaceuticals Inc’s (NASDAQ:FENC) Pedmark to reduce the risk of chemo-induced ototoxicity in pediatric patients. Pedmark is indicated…

FENC

1 minute read

Some Medtronic’s Insulin Pumps Are Associated With Cybersecurity Risk, FDA Says

By Vandana Singh

September 21, 12:37 PM

The FDA warned that certain types of Medtronic Inc’s (NYSE:MDT) MiniMed 600 Series insulin pump system were vulnerable to cyberattacks. Hackers could…

MDT

1 minute read

Intercept Pharma Summarizes Key Actions in Strategic Financial Repositioning

By Vandana Singh

September 21, 11:33 AM

Intercept Pharmaceuticals Inc (NASDAQ:ICPT) announced a summary of its actions to improve its capital position, including the recently announced private repurchases…

ICPT

1 minute read

Cidara’s Lead Antifungal Candidate Goes Under Priority FDA Review

By Vandana Singh

September 21, 10:27 AM

The FDA accepted Cidara Therapeutics Inc’s (NASDAQ:CDTX) marketing application seeking approval for rezafungin for candidemia and invasive candidiasis. Under the priority…

CDTX

1 minute read

Pulse Biosciences Shifts Core Technology Focus, Reduces Dermatologic Footprint

By Vandana Singh

September 21, 10:03 AM

Bioelectric medicine company Pulse Biosciences Inc (NASDAQ:PLSE) announced a shift in focus to advance core NPS technology in the cardiac and oncology…

PLSE

1 minute read

Adamis Pharma Shares Nosedive As Its COVID-19 Candidate Shows No Efficacy

By Vandana Singh

September 21, 9:58 AM

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) announced the results from the third planned interim analysis of the Phase 2/3 clinical trial of Tempol in high-risk subjects with early COVID-19 infection.

ADMP

1 minute read

Argenx Seeks FDA Nod For Its Flagship Neuromuscular Treatment Formulated For Subcutaneous Injection

By Vandana Singh

September 21, 9:58 AM

Argenx SE (NASDAQ: ARGX) has

ARGX